Silexion Therapeutics GAAP EPS of -$26.36
Source: SeekingAlpha
2025-03-18 16:40:12 ET
More on Silexion Therapeutics
- Seeking Alpha’s Quant Rating on Silexion Therapeutics
- Historical earnings data for Silexion Therapeutics
- Financial information for Silexion Therapeutics
Read the full article on Seeking Alpha
For further details see:
Silexion Therapeutics GAAP EPS of -$26.36
Silexion Therapeutics Corp
NASDAQ: SLXN
SLXN Trading
1202.95% G/L:
$5.26 Last:
181,356 Volume:
$4.29 Open:
SLXN Latest News
May 20, 2026 01:20:00 pm
Biotech Stock Silexion Therapeutics Corp. (NASDAQ: SLXN) Soars on Update and First Quarter Results
May 20, 2026 11:49:53 am
Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation
May 18, 2026 08:30:00 am
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
SLXN Stock Data
$5,158,959
2,939,043
62.46%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Ramat-Gan
